Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(55.6%)
Phase 1
4(44.4%)
9Total
N/A(5)
Phase 1(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT06680154Not ApplicableCompleted

Induction and Stabilization of Gamma Oscillations With 40 Hz External Brain Stimulation

Role: collaborator

NCT06740864Not ApplicableCompleted

40 Hz Transcranial Alternating Current Stimulation for Inducing Gamma Oscillations

Role: collaborator

NCT06155786Not ApplicableCompleted

Cognitive Effects of tDCS and tRNS in Schizophrenia

Role: collaborator

NCT06165445Not ApplicableCompleted

Optimizing tDCS Protocol for Clinical Use in Major Depressive Disorder

Role: collaborator

NCT05501132Phase 1Completed

Efficacy of Intensified Transcranial Direct Current Stimulation in Obsessive-compulsive Disorder

Role: collaborator

NCT07169721Completed

CIRCAdian Rhythm of the IMMune Age IndeX (IMMAX)

Role: lead

NCT06974136Not ApplicableRecruiting

tES Modalities for the Treatment of ADHD

Role: collaborator

NCT05200962Phase 1Unknown

Electrical Brain Stimulation for Cognitive Impairment in Schizophrenia: a tDCS-fMRI Study

Role: collaborator

NCT05491720Phase 1Completed

Electrical Brain Stimulation and Pharmacological Treatments in Autism Spectrum Disorder

Role: collaborator

NCT05342727Phase 1Completed

Transcranial Direct and Alternating Stimulation of the Prefrontal Cortex for Cognitive Improvement in Schizophrenia

Role: collaborator

All 10 trials loaded